The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies

Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus

(2017) Ioanna Eleftheriadou et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Fetuin-A and Risk of Diabetes Independent of Liver Fat Content

(2016) Sarah A. Aroner et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

From infancy to aging: Biological and behavioral modifiers of Fetuin-A

(2016) Katie N. Robinson et al.   BIOCHIMIE

Plasma fetuin-A/α2-HS-glycoprotein correlates negatively with inflammatory cytokines, chemokines and activation biomarkers in individuals with type-2 diabetes

(2016) Sardar Sindhu et al.   BMC IMMUNOLOGY

Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy

(2016) Zhong-Wei Zhou et al.   CLINICA CHIMICA ACTA

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

(2016) Alexandra Kautzky-Willer et al.   ENDOCRINE REVIEWS

Inflammatory Markers in Obese Adolescents with Type 2 Diabetes and Their Relationship to Hepatokines and Adipokines

(2016) Thomas Reinehr et al.   JOURNAL OF PEDIATRICS

Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: A case-control study

(2016) Sahar A. Ali et al.   Clinics and Research in Hepatology and Gastroenterology

Hepatokines: unlocking the multi-organ network in metabolic diseases

(2015) Alison Iroz et al.   DIABETOLOGIA

Relationship of fibroblast growth factor 23 and fetuin-A to coronary atherosclerosis

(2015) Fatih Akin et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy

(2015) Rui Jiang   MEDICAL SCIENCE MONITOR

Hepatokines as a Link between Obesity and Cardiovascular Diseases

(2015) Hye Jin Yoo et al.   Diabetes & Metabolism Journal

Biomarkers of Vascular Calcification and Mortality in Patients with ESRD

(2014) J. J. Scialla et al.   Clinical Journal of the American Society of Nephrology

High plasma fetuin-A levels are associated with metabolic syndrome among males but not females in a Japanese general population

(2014) Aya Obuchi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India

(2014) D. Dutta et al.   DIABETIC MEDICINE

Fetuin-A: a novel link between obesity and related complications

(2014) J F Trepanowski et al.   INTERNATIONAL JOURNAL OF OBESITY

Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies

(2014) Norbert Stefan et al.   PLoS One

Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression

(2014) Akinobu Ochi et al.   PLoS One

Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A

(2013) Tae Woo Jung et al.   BIOCHEMICAL PHARMACOLOGY

Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes

(2013) Zi-Wen Zhao et al.   BIOMARKERS

Serum Levels of Fetuin-A, Osteoprotegerin and Osteopontin in Patients with Coronary Artery Disease: Effects of Statin (HMGCoA-Reductase Inhibitor) Therapy

(2013) Nikolaos P. E. Kadoglou et al.   CLINICAL DRUG INVESTIGATION

Sex-Specific Association of Fetuin-A With Type 2 Diabetes in Older Community-Dwelling Adults: The Rancho Bernardo Study

(2013) G. A. Laughlin et al.   DIABETES CARE

Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease

(2013) Steven K. Malin et al.   JOURNAL OF APPLIED PHYSIOLOGY

Adipocyte Fetuin-A Contributes to Macrophage Migration into Adipose Tissue and Polarization of Macrophages

(2013) Priyajit Chatterjee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Comparison of Coronary Artery Calcification and Some Coronary Artery Calcification Risk Factors in Patients on Haemodialysis and in Patients with Type 2 Diabetes

(2013) M Krajnc et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

The role of hepatokines in metabolism

(2013) Norbert Stefan et al.   Nature Reviews Endocrinology

The Ratio of Osteoprotegerin to Fetuin-A Is Independently Associated with Vascular Stiffness in Hemodialysis Patients

(2013) Hye Ryoun Kim et al.   NEPHRON CLINICAL PRACTICE

Association of Fetuin-A With Incident Diabetes Mellitus in Community-Living Older Adults

(2012) Joachim H. Ix et al.   CIRCULATION

Anti-Inflammatory Role of Fetuin-A in Injury and Infection

(2012) H. Wang et al.   CURRENT MOLECULAR MEDICINE

Plasma Levels of Fetuin-A and Hepatic Enzymes and Risk of Type 2 Diabetes in Women in the U.S.

(2012) Qi Sun et al.   DIABETES

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

(2012) Durba Pal et al.   NATURE MEDICINE

Relationship of fetuin-A levels to weight-dependent insulin resistance and type 2 diabetes mellitus

(2012) Johannes Erdmann et al.   REGULATORY PEPTIDES

Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes

(2011) Horng-Yih Ou et al.   CLINICAL ENDOCRINOLOGY

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies

(2011) John Willy Haukeland et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Serum Fetuin-A is an Independent Marker of Insulin Resistance in Japanese Men

(2011) Ayako Ishibashi et al.   Journal of Atherosclerosis and Thrombosis

Secretome analysis of rat adipose tissues shows location-specific roles for each depot type

(2011) Arturo Roca-Rivada et al.   Journal of Proteomics

Serum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults

(2011) Aiyun Song et al.   PLoS One

Gender differences in rat plasma proteome in response to high-fat diet

(2011) Hao Liu et al.   PROTEOMICS

Serum Visfatin and Fetuin-A Levels and Glycemic Control in Patients with Obese Type 2 Diabetes Mellitus

(2011) Fethiye Oztop Gunduz et al.   Diabetes & Metabolism Journal

NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance

(2010) Suman Dasgupta et al.   BIOCHEMICAL JOURNAL

Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy

(2010) Marcel Roos et al.   Cardiovascular Diabetology

Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?

(2010) Edward R. Smith et al.   CLINICA CHIMICA ACTA

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease

(2010) D. P. Lorant et al.   DIABETES CARE

Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss

(2010) Johanna Maria Brix et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mechanisms Linking Obesity, Chronic Kidney Disease, and Fatty Liver Disease: The Roles of Fetuin-A, Adiponectin, and AMPK

(2010) J. H. Ix et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Plasma fetuin-A concentrations in young and older high- and low-active men

(2010) Nathan T. Jenkins et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4

(2010) M. L. Ford et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes

(2010) Anke Tönjes et al.   PLoS One

Association of AHSG Gene Polymorphisms With Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study

(2009) Eva Fisher et al.   Circulation-Cardiovascular Genetics

Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes

(2009) L. H. Eraso et al.   DIABETES CARE

Diagnosis and Classification of Diabetes Mellitus

(2009)   DIABETES CARE

Is Fetuin-A/α2-Heremans-Schmid Glycoprotein Associated with the Metabolic Syndrome in Patients with Chronic Kidney Disease?

(2008) Jonas Axelsson et al.   AMERICAN JOURNAL OF NEPHROLOGY

Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes

(2008) N. Stefan et al.   DIABETES

Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients

(2008) G. Metry et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Fetuin-A and Incident Diabetes Mellitus in Older Persons

(2008) Joachim H. Ix   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production

(2008) Anita M. Hennige et al.   PLoS One

A promoter polymorphism of the α2-HS glycoprotein gene is associated with its transcriptional activity

(2007) Mari Inoue et al.   DIABETES RESEARCH AND CLINICAL PRACTICE